OurPharma LLC
FDA 503B outsourcing facility
Fayetteville, Arkansas
Key Takeaways
- FDA-registered 503B outsourcing facility since 2019
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: September 27, 2024
- 3 FDA drug recalls on record (2022 to 2025)
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- March 15, 2019
- Most recent registration
- November 26, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- September 27, 2024
The FDA last inspected OurPharma LLC on September 27, 2024. Investigators issued a Form FDA 483 listing inspectional observations at that visit. The FDA has not yet determined whether further action will be taken.
FDA recall history
OurPharma LLC has 3 FDA drug recalls on record between 2022 and 2025, based on the FDA enforcement database. Breakdown: 1 Class II, 2 Class III.
Recall reasons on record include superpotent drug: assay/potency result for hydromorphone hcl in the compounded stability; short fill: underfilled units; underfilled units.
| Date | Class | Product | Reason |
|---|---|---|---|
| April 2025 | Class III | HYDROmorphone Hydrochloride 50mg/50mL (1mg/mL), packaged in a 50 mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, | Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification.. |
| January 2023 | Class III | FentaNYL Citrate 2.5mg/50mL (50mcg/mL) Injection Solution, Preservative-Free IV Injection 50mL Cassette, Rx Only, OurPharma, LLC, 2512 S. Ci | Short Fill: Underfilled units. |
| November 2022 | Class II | FentaNYL Citrate 2.5 mg/50 mL (50mcg/ml) Injection Solution, Preservative Free, Single Use 50 ml Cassette, Rx Only, Repackaged by OurPharma, | Underfilled units. |
FDA recall classes signal severity, not intent: Class I means a reasonable probability of serious harm, Class II a temporary or reversible risk, Class III a violation unlikely to cause harm. Sterile compounders routinely recall lots as a precaution. FDA definitions.
What this facility compounds
OurPharma LLC reports compounding 9 distinct active ingredients to the FDA Outsourcing Facility Product Report (most recent reporting periods).
Tracked on PeptideGrids: Semaglutide.
- Bupivacaine Hydrochloride; Fentanyl Citrate
- Fentanyl Citrate
- Fentanyl Citrate; Bupivacaine Hydrochloride
- Fentanyl Citrate; Ropivacaine Hydrochloride
- Hydromorphone Hydrochloride
- Ketamine Hydrochloride
- Morphine Sulfate
- Ropivacaine Hydrochloride
- Semaglutide
Location
2512 S City Lake Rd, N/A, Fayetteville, AR 72701-5013
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Shelby Bush Ext 8227, 479-313-8200. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of OurPharma LLC with the Arkansas State Board of Pharmacy.
503B facilities in Arkansas
Arkansas has 3 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Arkansas.
Frequently asked questions
Is OurPharma LLC registered with the FDA?
Yes. OurPharma LLC is a registered 503B outsourcing facility, first registered with the FDA on March 15, 2019 and most recently registered on November 26, 2025.
Has OurPharma LLC been inspected by the FDA?
The FDA last inspected OurPharma LLC on September 27, 2024. A Form FDA 483 was issued.
Has OurPharma LLC had any FDA drug recalls?
OurPharma LLC has 3 FDA drug recalls on record (2022 to 2025) in the FDA enforcement database.
What does OurPharma LLC compound?
OurPharma LLC reports compounding 9 active ingredients to the FDA, including Semaglutide.
Where is OurPharma LLC located?
OurPharma LLC is located in Fayetteville, Arkansas (2512 S City Lake Rd).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026. Recall history from the FDA openFDA drug enforcement database, retrieved June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by OurPharma LLC. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.